complaint·September 13, 2023

(Continue from LIC9099) On September 13, 2023, during a visit to the facility, a detailed review of R1’s medication administration records (MARs) disclosed that the Xanax medication for anxiety and sleep aid was to be administered 2x a day. This medication had a physician’s order stop date of 9/1/2023, and a new physician’s order was written on September 3, 2023, as a PRN (pro re nata) or as-needed basis. A detailed review of R1’s medication administration records indicated this medication was administered as prescribed. However, the Xidra eye drops were not administered as prescribed from August 7-15, 2023. A review of the MARs indicated the medication was “awaiting delivery”. There were no staff notes indicating that staff followed up with the pharmacy. Discussions with facility management indicated that the facility's standard protocols require medication technicians to follow up with the pharmacy as needed and to record follow-up attempts to ensure medications were administered as prescribed. Based on observations, staff interviews, and records review there was sufficient evidence to support the allegation that staff did not administer medications in accordance with doctor's orders. The Department has investigated the above-mentioned allegation and has found that there was sufficient evidence to corroborate the allegation. Therefore, this allegation is substantiated. A substantiated finding means the allegation is valid because the preponderance of the evidence standard has been met. A deficiency was cited per Title 22, Division 6, Chapter 8 of the California Code of Regulations and is listed on LIC 9099-D. A plan of corrections was developed with Executive Director, Emily De La Barre. An exit interview was conducted with Executive Director, Emily De La Barre and a copy of this report, Confidential Name List (LIC 811), along with Licensee/Appeal Rights (LIC 9058 03/22) were provided at the conclusion of the visit via email. Medication Technician, Alondra Martinez signed the report for Executive Director, DeLa Barre due to her absence. Report was emailed to Executive Director, Emily DeLaBarre with a confirmation receipt request at ed.bonita@pacificaseniorliving.com .